General Practice Doctors in Crewe, VA Accepting Medicare
1 General Practice doctors found. Showing 1 - 1
 Dr. John E Gehman Sr., MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 306 Custis St # A, Crewe, VA 23930 Phone: 434-538-0345 Fax: 434-538-0285 |
News Archive
UNC and partners receive NIH funding to identify chlamydia vaccine
Chlamydia is the most prevalent bacterial sexually transmitted infection (STI) in the world. There is no vaccine to prevent infection. However, researchers from the University of North Carolina at Chapel Hill, in partnership with colleagues at other sites in the US, Europe and Australia, will receive up to $10.7 million over five years from the National Institutes of Health (NIH) to move closer to identifying a vaccine candidate.
Leaky blood vessels may cause sepsis rather than a symptom: Research
Researchers at St. Michael's Hospital have put forward a new theory as to what causes sepsis, an often fatal condition that occurs when infection spreads throughout the body.
Researchers discuss imaging techniques for early diagnosis and treatment of Alzheimer's disease
With about 35 million people around the world suffering from Alzheimer's disease (AD) by the year 2010 and an expectation that these numbers will double every twenty years with approximately 115 million cases by 2050, pressure on healthcare systems worldwide will be intense. In a special issue of the journal Behavioural Neurology, twelve contributions from an international group of researchers discuss imaging techniques that may contribute to early diagnosis and advancements in treatment for this devastating disease.
Depressive symptoms, mood may predict momentary pain among patients with rheumatoid arthritis
Depressive symptoms and mood in the moment may predict momentary pain among rheumatoid arthritis patients, according to Penn State researchers.
Eisai transfers rights to Royalty Pharma relating to net sales of EZH2 inhibitor outside of Japan
Eisai Co., Ltd. announced today that it has entered into an agreement to transfer the rights to receive royalties on the sales outside of Japan for an investigational anti-cancer agent tazemetostat (generic name) to Royalty Pharma.
› Verified 3 days ago